Zepbound (Tirzepatide) Zepbound is a dual-action injectable targeting GLP-1 and GIP hormones, designed for those requiring pronounced weight loss benefits
doi:10.2337/dc19-0415 He L, Wang J, Ping F, Yang N, Huang J, Li Y, Xu L, Li W, Zhang H
These additions may support energy levels, metabolism, or overall well-being during the weight loss process
The relevance to tirzepatide is indirect, but the low risk profile makes it a reasonable adjunct when anxiety-mediated nausea worsens vomiting
Mechanism of Action Tirzepatide's dual receptor activity produces complementary and synergistic metabolic effects: GLP-1 Agonism: Stimulates glucose-dependent insulin secretion, suppresses glucagon release, slows gastric emptying, and reduces appetite via central nervous system pathways
In a large Novo Nordiskfunded study published in The New England Journal of Medicine , the degree of weight reduction in adolescents was better than what was observed in the adult trials, Aaron S